JENNIFER HOLEMAN: Open Payments
NPI 1376804781 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 62 payments from 17 companies in 2025. Trend: 2023 $640 · 2024 $1,960 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $218 |
| Forte Bio-Pharma LLC | 12 | $181 |
| Teva Pharmaceuticals USA, Inc. | 5 | $122 |
| ABBVIE INC. | 6 | $111 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $78 |
| Lundbeck LLC | 3 | $77 |
| Antares Pharma, Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 3 | $48 |
| Averitas Pharma Inc. | 2 | $46 |
Products named: RELISTOR, PROLATE, AJOVY, UBRELVY, JOURNAVX, VYEPTI, XYOSTED, REXULTI.
Industry payments across OK — which companies pay providers there.
